ACCENTIA BIOPHARMACEUTICALS INC 8-K (Events or Changes Between Quarterly Reports) 2009-02-20

Processed and formatted by SEC Watch - Visit SECWatch.
com
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 20, 2009
ACCENTIA BIOPHARMACEUTICALS, INC.

(Exact n am e of Re gistran t as S pe cifie d in its C h arte r)
Florida 000-51383 04-3639490

(State or oth e r jurisdiction of (C om m ission File Nu m be r) (I.R.S . Em ploye r
incorporation or organ iz ation) Ide n tification No.)
324 South Hyde Park Ave., Suite 350

Tampa, Florida 33606
(Addre ss of Principal Exe cu tive O ffice s; Zip C ode )
Registrant’s telephone number, including area code: (813) 864-2554
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of
the following provisions:
® Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
® Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
® Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2-(b))
® Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Processed and formatted by SEC Watch - Visit SECWatch.com
FORM 8-K
Item 7.01. Regulation FD Disclosure.

On February 20, 2009, the Company and certain of its affiliates (collectively, the “Debtors”) filed their unaudited combined monthly operating
report for the period January 1, 2009 through January 31, 2009 (the “Monthly Operating Report”) with the United States Bankruptcy Court for
the Middle District of Florida, Tampa Division (the “Bankruptcy Court”). Exhibit 99-1 to this Current Report on Form 8-K contains the
unaudited Monthly Operating Report as filed with the Bankruptcy Court.
The Monthly Operating Report is limited in scope, covers a limited time period and has been prepared solely for the purpose of complying with
reporting requirements of the Bankruptcy Court and the Bankruptcy Code, 11 U.S.C. §§ 101-1532 (the “Bankruptcy Code”). The financial
information contained in the Monthly Operating Report is preliminary and unaudited and does not purport to show the financial statements of
any of the Debtors in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and, therefore, may
exclude items required by GAAP, such as certain reclassifications, eliminations, accruals and disclosure items. The Company cautions readers
not to place undue reliance on the Monthly Operating Report. The Monthly Operating Report may be subject to revision. The Monthly
Operating Report is in a format required by the Bankruptcy Court and the Bankruptcy Code and should not be used for investment purposes.
The information in the Monthly Operating Report should not be viewed as indicative of future results.
This Current Report on Form 8-K sets forth statements that are not strictly historical in nature and such statements are referred to as “forward-
looking statements.” The forward-looking statements in this Form 8-K include statements about our product development programs, clinical
trials for our BiovaxID® and SinuNaseTM products and potential future market opportunity. Such forward-looking statements are subject to
known and unknown risks, uncertainties, and other factors that may cause our actual results to be materially different from any results
expressed or implied by such forward-looking statements. These factors include, but are not limited to, risks and uncertainties related to the
progress, timing, cost, and results of the Company’s clinical trials and product development programs. All forward looking statements in this
Form 8-K are qualified in their entirety by this cautionary statement, and we undertake no obligation to revise or update this Current Report on
Form 8-K to reflect events or circumstances after the date hereof.
Limitation on Incorporation by Reference

The Monthly Operating Report is being furnished for informational purposes only and shall not be deemed “filed” for purposes of Section 18
of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall they be deemed
incorporated by reference in any filing under the Securities Act of 1933, as amended. Registration statements or other documents filed with the
U.S. Securities and Exchange Commission (“SEC”) shall not incorporate the Monthly Operating Report or any other information set forth in
this Current Report on Form 8-K by reference, except as otherwise expressly stated in such filing. This Current Report on Form 8-K will not be
deemed an admission as to the materiality of any information in the report that is required to be disclosed solely by Regulation FD.
Item 9.01. Financial Statements and Exhibits.

See the Exhibit Index set forth below for a list of exhibits included with this Form 8-K.
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunder duly authorized.
By: /s/ Samuel S. Duffey

Samuel S. Duffey
President & General Counsel
Date: February 20, 2009

EXHIBIT INDEX
Exh ibit
Nu m be r De scription
99.1 Monthly Operating Report of Accentia Biopharmaceuticals, Inc. for the period January 1, 2009 through January 31, 2009 filed in the
United States Bankruptcy Court Middle District of Florida Case No. 8:08-bk-17795-KRM Document No. 190
Exhibit 99.1
SCHEDULE OF RECEIPTS AND DISBURSEMENTS
FOR THE PERIOD BEGINNING: January 1, 2009 Period ending January 31, 2009
Name of Debtor: Accentia Biopharmaceuticals, Inc. Case Number: 8:08-bk-17795-KRM
Date of Petition: November 10, 2008
C URRENT C UMULATIVE
MO NTH PETITIO N TO DATE
1. FUNDS AT BEGINNING OF PERIOD $299,808.08 $ 281,590.31
2. RECEIPTS:
A. Cash Sales
B. Accounts Receivable
C. Other Receipts (See MOR-3) 18,814.77 328,432.98
D. Transfer from subsidiaries - TEAMM — 215,644.58
- Analytica 292,533.20 530,734.91
- A.S.P. — 30,731.41
- AccentRx 4,327.23 4,327.23
- Biovest (shared expenses) 40,855.58 152,646.96
3. TOTAL RECEIPTS (Lines 2A+2B+2C) 356,530.78 1,262,518.07
4. TOTAL FUNDS AVAILABLE FOR OPERATIONS (1+3) 656,338.86 1,544,108.38
5. DISBURSEMENTS
A. Advertising — —
B. Bank Charges / Payroll Fees 4,885.18 6,231.42
C. Contract Labor — —
D. Fixed Asset Payments (not incl in N) — —
E. Insurance 52,647.85 236,698.16
F. Inventory Payments (See Attach. 2) — —
G. Leases 1,343.30 2,288.85
H. Manufacturing Supplies — —
I. Office Supplies 3,552.21 4,341.44
J. Payroll – Net (see Attachment 4B) 88,224.02 352,440.21
K. Professional Fees (Accounting/Legal) 19,577.84 21,617.84
L. Rent 15,089.50 44,083.76
M. Repairs and Maintenance 360.00 360.00
N. Secured Creditor Payments (Attach. 2) — —
O. Taxes Paid – Payroll (Attach. 4C) 44,580.45 183,540.71
P. Taxes Paid – Sales and Use (Attach. 4C) — —
Q. Taxes Paid – Other (Attach. 4C) — 1,000.00
R. Telephone / Internet 6,093.84 19,677.22
S. Travel and Entertainment 106.80 14,648.06
Y. U.S. Trustee Quarterly Fees 12,025.00 12,025.00
U. Utilities — 819.31
V. Vehicle Expenses — —
W. Other Operating Expenses (See MOR-3) 1,200.00 26,829.71
X. Transfer to subsidiaries - Analytica 84,231.15 270,084.97
- Biovest(shared expenses) — 25,000.00
TOTAL DISBURSEMENTS (Sum of 5A thru W) 333,917.14 1,221,686.66
ENDING BALANCE (Line 4 Minus Line 6)(c) 322,421.72 322,421.72
I declare under penalty of perjury that this statement and the accompanying documents and reports are true and correct to the best of my
knowledge and belief.
This 20th day of February, 2009 / S / Alan M. Pearce

(Signature)
(a) This number is carried forward from last month’s report. For the first report only, this number will be the balance as of the petition date.
(b) This figure will not change from month to month. It is always the amount of funds on hand as of the date of the petition.
(c) These two amounts will always be the same if form is completed correctly.
MOR-1
MONTHLY SCHEDULE OF RECEIPTS AND DISBURSEMENTS (cont’d)
Detail of Other Receipts and Other Disbursements
OTHER RECEIPTS:
Describe Each Item of Other Receipt and List Amount of Receipt. Write totals on Page MOR-2, Line 2C.
C u m u lative
De scription C u rre n t Month Pe tition to Date
Collections for TEAMM receivables and Cobra $ 0 $ 278,852.74
Collections for A.S.P. receivables 10,152.03 19,488.21
Collections for Analytica 0 $ 6,975.00
COBRA checks for Accentia 8,662.74 23,117.03
TOTAL OTHER RECEIPTS $ 18,814.77 $ 328,432.98
“Other Receipts” includes Loans from Insiders and other sources (i.e. Officer/Owner, related parties directors, related corporations, etc.).
Please describe below: N/A
Loan Am ou n t S ou rce of Fu n ds Purpose Re paym e n t Sch e du le

N/A
OTHER DISBURSEMENTS:
Describe Each Item of Other Disbursement and List Amount of Disbursement. Write totals on Page MOR-2, Line 5W.
C u m u lative
De scription C u rre n t Month Pe tition to Date
Southeastern Document Service – document handling for bankruptcy filing $ 0 $ 1,247.60
RR Donnelly – SEC filings $ 1,200.00 $ 4,700.00
Garrison Hasara – overnight postage charge for payroll disbursement (Fed-Ex refused service) $ 0 $ 1,087.24
Bill McNulty – moving expenses (closed 2nd floor of Tampa office) $ 0 $ 986.57
Promontech – sample inventory destruction $ 0 $ 18,808.30
TOTAL OTHER DISBURSEMENTS $ 1,200.00 $ 26,829.71
NOTE: Attach a current Balance Sheet and Income (Profit & Loss) Statement.
MOR-2
ATTACHMENT 1
MONTHLY ACCOUNTS RECEIVABLE RECONCILIATION AND AGING
Reporting Period beginning January 1, 2009 Period ending January 31, 2009
ACCOUNTS RECEIVABLE AT PETITION DATE: N/A
ACCOUNTS RECEIVABLE RECONCILIATION
(Include all accounts receivable, pre-petition and post-petition, including charge card sales which have not been received):
Beginning of Month Balance (a) $

PLUS: Current Month New Billings
MINUS: Collection During the Month(b) $
PLUS/MINUS: Adjustments or Write-offs* $
End of Month Balance(c) $
* For any adjustments or Write-offs provide explanation and supporting documentation, if applicable:
POST PETITION ACCOUNTS RECEIVABLE AGING

(Show the total for each aging category for all accounts receivable)
0-30 Days 31-60 Days 61-90 Days O ve r 90Days Total (c)

$ $ $ $ $
For any receivables in the “Over 90 Days” category, please provide the following: N/A
S tatu s (C olle ction e fforts

take n , e stim ate of colle ctability,
Re ce ivable C u stom e r Date write -off, dispu te d accoun t, e tc.)
N/A
(b) This must equal the number reported in the “Current Month” column of Schedule of Receipts and Disbursements (Page MOR-2, Line 2B).
(c) These two amounts must equal.
MOR-3
ATTACHMENT 2
MONTHLY ACCOUNTS PAYABLE AND SECURED PAYMENTS REPORT

In the space below list all invoices or bills incurred and not paid since the filing of the petition. Do not include amounts owed prior to filing the
petition. In the alternative, a computer generated list of payables may be attached provided all information requested below is included. SEE
ATTACHED
POST-PETITION ACCOUNTS PAYABLE
Date
Date Incu rre d O u tstan ding Ve n dor De scription Am ou n t
See attached
TOTAL AMOUNT(b)
® Check here if pre-petition debts have been paid. Attach an explanation and copies of supporting documentation.
ACCOUNTS PAYABLE RECONCILIATION (Post Petition Unsecured Debt Only)
Opening Balance(a) $ 15,241.02

PLUS: New Indebtedness Incurred This Month 116,394.50
MINUS: Amount Paid on Post Petition, Accounts Payable This Month (111,916.34)
PLUS/MINUS: Adjustments * *
Ending Month Balance(c) $ 19,719.18
* For any adjustments provide explanation and supporting documentation, if applicable.
SECURED PAYMENTS REPORT
List the status of Payments to Secured Creditors and Lessors (Post Petition Only). If you have entered into a modification agreement with a
secured creditor/lessor, consult with your attorney and the United States Trustee Program prior to completing this section).
Date Nu m be r of Total Am ou n t of
Paym e n t Am ou n t Post Pe tition Post Pe tition
Du e Th is Paid Th is Paym e n ts Paym e n ts
S e cu re d C re ditor/Le ssor Mon th Mon th De lin qu e n t De lin qu e n t
N/A
Total(d)
(a) This number is carried forward from last month’s report. For the first report only, this number will be zero.
(b, c) The total of line (b) must equal line (c).
(d) This number is reported in the “Current Month” column of Schedule of Receipts and Disbursements (Page MOR-2, Line 5N).
MOR-4
ATTACHMENT 3
INVENTORY AND FIXED ASSETS REPORT

INVENTORY REPORT
INVENTORY BALANCE AT PETITION DATE: $N/A

INVENTORY RECONCILIATION:
Inventory Balance at Beginning of Month(a) $
PLUS: Inventory Purchased During Month $
MINUS: Inventory Used or Sold $
PLUS/MINUS: Adjustments or Write-downs* $
Inventory on Hand at End of Month $
METHOD OF COSTING INVENTORY:

* For any adjustments or write-downs provide explanation and supporting documentation, if applicable.
INVENTORY AGING
Le ss th an 6 6 m on ths to 2 Gre ate r than 2 C on side re d

m on ths old ye ars old ye ars old O bsole te Total
% % % % = 100%*
* Aging Percentages must equal 100%.
® Check here if inventory contains perishable items.
Description of Obsolete Inventory:
FIXED ASSET REPORT

FIXED ASSETS FAIR MARKET VALUE AT PETITION DATE(b): $95,604.47
(Includes Property, Plant and Equipment)
BRIEF DESCRIPTION (First Report Only):
FIXED ASSETS RECONCILIATION:
Fixed Asset Book Value at Beginning of Month(a) (b) $82,944.71

MINUS: Depreciation Expense $ 4,203.77
PLUS: New Purchases —
PLUS/MINUS: Adjustments or Write-downs* —
Ending Monthly Balance $78,740.94
* For any adjustments or write-downs, provide explanation and supporting documentation, if applicable.
BRIEF DESCRIPTION OF FIXED ASSETS PURCHASED OR DISPOSED OF DURING THE REPORTING PERIOD: N/A
(b) Fair Market Value is the amount at which fixed assets could be sold under current economic conditions.
Book Value is the cost of the fixed assets minus accumulated depreciation and other adjustments.
MOR-5
ATTACHMENT 4A
MONTHLY SUMMARY OF BANK ACTIVITY—OPERATING ACCOUNT

Attach a copy of current month bank statement and bank reconciliation to this Summary of Bank Activity. A standard bank reconciliation form
can be found at http://www.usdoj.gov/ust/r21/index.htm. If bank accounts other than the three required by the United States Trustee Program
are necessary, permission must be obtained from the United States Trustee prior to opening the accounts. Additionally, use of less than the
three required bank accounts must be approved by the United States Trustee.
NAME OF BANK: Wachovia Bank, NA BRANCH:

ACCOUNT NAME: Accentia Master Account DIP ACCOUNT NUMBER:*********1478
PURPOSE OF ACCOUNT: MASTER ACCOUNT
Ending Balance per Bank Statement $335,249.47

Plus Total Amount of Outstanding Deposits $ 0
Minus Total Amount of Outstanding Checks and other debits* $ 0
Minus Service Charges $ 0
Ending Balance per Check Register**(a) $335,249.47
* Debit cards are used by N/A
** If Closing Balance is negative, provide explanation: N/A
The following disbursements were paid in Cash (do not include items reported as Petty Cash on Attachment 4D: (® Check here if cash
disbursements were authorized by United States Trustee)
Date Am ou n t Paye e Purpose Re ason for C ash Disburse m e n t
TRANSFERS BETWEEN DEBTOR IN POSSESSION ACCOUNTS
“Total Amount of Outstanding Checks and other debits”, listed above, includes:
$ Transferred to Payroll Account

$ Transferred to Tax Account
(a) The total of this line on Attachment 4A, 4B and 4C plus the total of 4D must equal the amount reported as “Ending Balance” on Schedule
of Receipts and Disbursements (Page MOR-2, Line 7).
MOR-6
ATTACHMENT 5A
CHECK REGISTER—OPERATING ACCOUNT

NAME OF BANK: Wachovia Bank, NA BRANCH: Tampa

ACCOUNT NAME: Accentia Operating ACCOUNT NUMBER: *********1478
PURPOSE OF ACCOUNT: MASTER ACCOUNT
Account for all disbursements, including voids, lost checks, stop payments, etc. In the alternative, a computer generated check register can be
attached to this report, provided all the information requested below is included. NONE
C HEC K
DATE NUMBER PAYEE PURPO S E AMO UNT
TOTAL $
MOR-7
ATTACHMENT 4A2
MONTHLY SUMMARY OF BANK ACTIVITY—OPERATING ACCOUNT

can be found at http://www.usdoj.gov/ust/r21/index.htm. If bank accounts other than the three required by the United States Trustee Program
are necessary, permission must be obtained from the United States Trustee prior to opening the accounts. Additionally, use of less than the
three required bank accounts must be approved by the United States Trustee.
NAME OF BANK: Wachovia Bank, NA BRANCH:

ACCOUNT NAME: Accentia Operating Account DIP ACCOUNT NUMBER:*********1494
PURPOSE OF ACCOUNT: OPERATING
Ending Balance per Bank Statement $ 0

Plus Total Amount of Outstanding Deposits $ 0
Minus Total Amount of Outstanding Checks and other debits* $(12,827.75)
Minus Service Charges $ 0
Ending Balance per Check Register**(a) $(12,827.75)
* Debit cards are used by N/A
The following disbursements were paid in Cash (do not include items reported as Petty Cash on Attachment 4D: (® Check here if cash
disbursements were authorized by United States Trustee)
MOR-8
ATTACHMENT 5A2
CHECK REGISTER—OPERATING ACCOUNT

NAME OF BANK: Wachovia Bank, NA BRANCH: Tampa

ACCOUNT NAME: Accentia Operating ACCOUNT NUMBER: *********1494
PURPOSE OF ACCOUNT: OPERATING
Account for all disbursements, including voids, lost checks, stop payments, etc. In the alternative, a computer generated check register can be
attached to this report, provided all the information requested below is included. SEE SEPARATE REGISTER
C HEC K
TOTAL $
MOR-9
ATTACHMENT 4B
MONTHLY SUMMARY OF BANK ACTIVITY - PAYROLL ACCOUNT

can be found at http://www.usdoj.gov/ust/r21/index.htm.
NAME OF BANK: N/A BRANCH: N/A

ACCOUNT NAME: ACCOUNT NUMBER:
PURPOSE OF ACCOUNT: PAYROLL
Ending Balance per Bank Statement $

Plus Total Amount of Outstanding Deposits $
Minus Total Amount of Outstanding Checks and other debits* $
Minus Service Charges $
Ending Balance per Check Register**(a) $
* Debit cards must not be issued on this account.
** If Closing Balance is negative, provide explanation:
The following disbursements were paid by Cash: (® Check here if cash disbursements were authorized by United States Trustee)
Re ason for C ash

Date Am ou n t Paye e Purpose Disburse m e n t
The following non-payroll disbursements were made from this account:
Re ason for Disburse m e n t

Date Am ou n t Paye e Purpose from accou n t
MOR-10
ATTACHMENT 5B
CHECK REGISTER—PAYROLL ACCOUNT


PURPOSE OF ACCOUNT: PAYROLL
Account for all disbursements, including voids, lost payments, stop payment, etc. In the alternative, a computer generated check register can
be attached to this report, provided all the information requested below is included.
C HEC K
TOTAL $
MOR-11
ATTACHMENT 4C
MONTHLY SUMMARY OF BANK ACTIVITY—TAX ACCOUNT
can be found on the United States Trustee website, http://www.usdoj.gov/ust/r21/index.htm.

PURPOSE OF ACCOUNT: TAX
Ending Balance per Bank Statement $

Plus Total Amount of Outstanding Deposits $
Minus Total Amount of Outstanding Checks and other debits* $
Minus Service Charges $
Ending Balance per Check Register**(a) $
* Debit cards must not be issued on this account.
The following disbursements were paid by Cash: (® Check here if cash disbursements were authorized by United States Trustee)
The following non-tax disbursements were made from this account: N/A
Re ason for Disburse m e n t

Date Am ou n t Paye e Purpose from accou n t
MOR-12
ATTACHMENT 5C
CHECK REGISTER—TAX ACCOUNT

PURPOSE OF ACCOUNT: TAX
Account for all disbursements, including voids, lost checks, stop payments, etc. In the alternative, a computer-generated check register can be
attached to this report, provided all the information requested below is included.
C HEC K
TOTAL (d) $
* This amount was paid by check through the Accentia Operating Account.
SUMMARY OF TAXES PAID
Payroll Taxes Paid(a) $44,580.45

Sales & Use Taxes Paid(b) $ 0
Other Taxes Paid(c) $ 0
TOTAL(d) $44,580.45
(a) This number is reported in the “Current Month” column of Schedule of Receipts and Disbursements (Page MOR-2, Line 5O).
(b) This number is reported in the “Current Month” column of Schedule or Receipts and Disbursements (Page MOR-2, Line 5P).
(c) This number is reported in the “Current Month” column of Schedule of Receipts and Disbursements (Page MOR-2, Line 5Q).
(d) These two lines must be equal.
MOR-13
ATTACHMENT 4D
INVESTMENT ACCOUNTS AND PETTY CASH REPORT
INVESTMENT ACCOUNTS
Each savings and investment account, i.e. certificates of deposits, money market accounts, stocks and bonds, etc., should be listed separately.
Attach copies of account statements.
Type of Negotiable
C u rre n t
Face Purchase Date of Mark e t
Instru m e n t Value Price Purchase Value
N/A
TOTAL(a) $
PETTY CASH REPORT
The following Petty Cash Drawers/Accounts are maintained:
(C olum n 3) (C olum n 4)
(C olum n 2) Am ou n t of Diffe re n ce
Maxim u m Pe tty C ash be twe e n
Am ou n t of C ash O n Hand At (C olum n 2)
Location of Box/Accoun t in Drawe r/Acct. En d of Mon th an d (C olum n 3)
N/A
TOTAL(b) $
For any Petty Cash Disbursements over $100 per transaction, attach copies of receipts. If there are no receipts, provide an explanation
TOTAL INVESTMENT ACCOUNTS AND PETTY CASH (a+ b) $ (c)
(c) The total of this line on Attachment 4A, 4B and 4C plus the total of 4D must equal the amount reported as “Ending Balance” on Schedule
MOR-14
ATTACHMENT 6
MONTHLY TAX REPORT
TAXES OWED AND DUE
Report all unpaid post-petition taxes including Federal and State withholding FICA, State sales tax, property tax, unemployment tax, State
workmen’s compensation, etc.
Date of
Last Tax
Date Re turn Tax Re turn
Nam e of Taxin g Au thority Paym e n t Due De scription Am ou n t File d Pe riod
N/A
TOTAL $
MOR-15
ATTACHMENT 7
SUMMARY OF OFFICER OR OWNER COMPENSATION
SUMMARY OF PERSONNEL AND INSURANCE COVERAGES
Report all forms of compensation received by or paid on behalf of the Officer or Owner during the month. Include car allowances, payments to
retirement plans, loan repayments, payments of Officer/Owner’s personal expenses, insurance premium payments, etc. Do not include
reimbursement for business expenses Officer or Owner incurred and for which detailed receipts are maintained in the accounting records.
Paym e n t
Nam e of O ffice r or O wn e r Title De scription Am ou n t Paid
Samuel Duffey President, General Counsel Salary $ 13,961.54
Alan Pearce C.F.O. Salary 11,452.18
James McNulty Treasurer Salary 4,634.68
PERSONNEL REPORT
Fu ll Tim e Part Tim e

Number of employees at beginning of period 13 1
Number hired during the period 0 0
Number terminated or resigned during period 0 0
Number of employees on payroll at end of period 13 1
CONFIRMATION OF INSURANCE
List all policies of insurance in effect, including but not limited to workers’ compensation, liability, fire, theft, comprehensive, vehicle, health
and life. For the first report, attach a copy of the declaration sheet for each type of insurance. For subsequent reports, attach a certificate of
insurance for any policy in which a change occurs during the month (new carrier, increased policy limits, renewal, etc.). SEE ATTACHED
Date
Phon e C ove rage Expiration Pre m ium
Age n t an d/or C arrie r Nu m be r Policy Nu m be r Type Date Du e
The following lapse in insurance coverage occurred this month: N/A
Date
Policy Type Date Lapse d Re instate d Re ason for Lapse
® Check here if U. S. Trustee has been listed as Certificate Holder for all insurance policies.
MOR-16
ATTACHMENT 8
SIGNIFICANT DEVELOPMENTS DURING REPORTING PERIOD
Information to be provided on this page, includes, but is not limited to: (1) financial transactions that are not reported on this report, such as
the sale of real estate (attach closing statement); (2) non-financial transactions, such as the substitution of assets or collateral;
(3) modifications to loan agreements; (4) change in senior management, etc. Attach any relevant documents. N/A
We anticipate filing a Plan of Reorganization and Disclosure Statement on or before .
MOR-17

ACCENTIA BIOPHARMACEUTICALS INC 8-K (Events or Changes Between Quarterly Reports) 2009-02-20

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

ACCENTIA BIOPHARMACEUTICALS INC 8-K (Events or Changes Between Quarterly Reports) 2009-02-20

Uploaded by

Copyright:

Available Formats

Processed and formatted by SEC Watch - Visit SECWatch.

ACCENTIA BIOPHARMACEUTICALS, INC.

Florida 000-51383 04-3639490

324 South Hyde Park Ave., Suite 350

Registrant’s telephone number, including area code: (813) 864-2554

ACCENTIA BIOPHARMACEUTICALS, INC.

Item 7.01. Regulation FD Disclosure.

Limitation on Incorporation by Reference

Item 9.01. Financial Statements and Exhibits.

ACCENTIA BIOPHARMACEUTICALS, INC.

By: /s/ Samuel S. Duffey

Date: February 20, 2009

SCHEDULE OF RECEIPTS AND DISBURSEMENTS

This 20th day of February, 2009 / S / Alan M. Pearce

MONTHLY SCHEDULE OF RECEIPTS AND DISBURSEMENTS (cont’d)

Detail of Other Receipts and Other Disbursements

Loan Am ou n t S ou rce of Fu n ds Purpose Re paym e n t Sch e du le

MONTHLY ACCOUNTS RECEIVABLE RECONCILIATION AND AGING

Name of Debtor: Accentia Biopharmaceuticals, Inc. Case Number: 8:08-bk-17795-KRM

ACCOUNTS RECEIVABLE AT PETITION DATE: N/A

ACCOUNTS RECEIVABLE RECONCILIATION

Beginning of Month Balance (a) $

POST PETITION ACCOUNTS RECEIVABLE AGING

0-30 Days 31-60 Days 61-90 Days O ve r 90Days Total (c)

S tatu s (C olle ction e fforts

MONTHLY ACCOUNTS PAYABLE AND SECURED PAYMENTS REPORT

Name of Debtor: Accentia Biopharmaceuticals, Inc. Case Number: 8:08-bk-17795-KRM

POST-PETITION ACCOUNTS PAYABLE

ACCOUNTS PAYABLE RECONCILIATION (Post Petition Unsecured Debt Only)

Opening Balance(a) $ 15,241.02

SECURED PAYMENTS REPORT

INVENTORY AND FIXED ASSETS REPORT

Name of Debtor: Accentia Biopharmaceuticals, Inc. Case Number: 8:08-bk-17795-KRM

INVENTORY BALANCE AT PETITION DATE: $N/A

METHOD OF COSTING INVENTORY:

Le ss th an 6 6 m on ths to 2 Gre ate r than 2 C on side re d

Description of Obsolete Inventory:

FIXED ASSET REPORT

BRIEF DESCRIPTION (First Report Only):

FIXED ASSETS RECONCILIATION:

Fixed Asset Book Value at Beginning of Month(a) (b) $82,944.71

MONTHLY SUMMARY OF BANK ACTIVITY—OPERATING ACCOUNT

Name of Debtor: Accentia Biopharmaceuticals, Inc. Case Number: 8:08-bk-17795-KRM

NAME OF BANK: Wachovia Bank, NA BRANCH:

PURPOSE OF ACCOUNT: MASTER ACCOUNT

Ending Balance per Bank Statement $335,249.47

Date Am ou n t Paye e Purpose Re ason for C ash Disburse m e n t

TRANSFERS BETWEEN DEBTOR IN POSSESSION ACCOUNTS

$ Transferred to Payroll Account

CHECK REGISTER—OPERATING ACCOUNT

Name of Debtor: Accentia Biopharmaceuticals, Inc. Case Number: 8:08-bk-17795-KRM

NAME OF BANK: Wachovia Bank, NA BRANCH: Tampa

PURPOSE OF ACCOUNT: MASTER ACCOUNT

MONTHLY SUMMARY OF BANK ACTIVITY—OPERATING ACCOUNT

Name of Debtor: Accentia Biopharmaceuticals, Inc. Case Number: 8:08-bk-17795-KRM

NAME OF BANK: Wachovia Bank, NA BRANCH:

Ending Balance per Bank Statement $ 0

Date Am ou n t Paye e Purpose Re ason for C ash Disburse m e n t

CHECK REGISTER—OPERATING ACCOUNT

Name of Debtor: Accentia Biopharmaceuticals, Inc. Case Number: 8:08-bk-17795-KRM

NAME OF BANK: Wachovia Bank, NA BRANCH: Tampa

MONTHLY SUMMARY OF BANK ACTIVITY - PAYROLL ACCOUNT

Name of Debtor: Accentia Biopharmaceuticals, Inc. Case Number: 8:08-bk-17795-KRM

NAME OF BANK: N/A BRANCH: N/A